Insider digest · ABBV
AbbVie insider filings, Oct 2, 2026
AbbVie insiders filed 2 routine Form 4 reports on Oct 2, 2026: awards. None of them was a purchase or a sale in the market. This page groups them in one place; each row links to the filing note, and each number links to the Form 4 itself.
What the codes mean: how to read a Form 4 · stock-based compensation.
Stock awards and grants
Shares or units the company granted as pay. No shares were bought or sold in the market. Total for the day: 188 shares or units, worth about $49,179 at the prices reported.
| Person | Code | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Edward J. Rapp · director | A | Stock Equivalent Units | 129 | $261.59 | $33,745 | 29,568 |
| Susan E. Quaggin · director | A | Stock Equivalent Units | 59 | $261.59 | $15,434 | 918 |
The filings
- AbbVie director Edward J. Rapp reports an award of 129 stock Equivalent units · SEC filing index
- AbbVie director Susan E. Quaggin reports an award of 59 stock Equivalent units · SEC filing index
AbbVie company file → · All AbbVie filings notes
Disclosures
- Editor holdings in ABBV
- The editor holds no position in AbbVie (ABBV). As of Nov 11, 2026.
- Compensation
- Nobody paid for this page. No affiliate links.
A summary of public filings for general education, the same for every reader. Not a recommendation to buy, sell or hold ABBV.